| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cysteine-type endopeptidase activator activity | 5.47e-06 | 5 | 165 | 3 | GO:0140608 | |
| GeneOntologyCellularComponent | multi-pass translocon complex | 3.92e-05 | 9 | 165 | 3 | GO:0160064 | |
| GeneOntologyCellularComponent | ER membrane insertion complex | 1.65e-04 | 14 | 165 | 3 | GO:0072379 | |
| GeneOntologyCellularComponent | Z disc | 2.00e-04 | 151 | 165 | 7 | GO:0030018 | |
| GeneOntologyCellularComponent | I band | 3.57e-04 | 166 | 165 | 7 | GO:0031674 | |
| GeneOntologyCellularComponent | canonical inflammasome complex | 3.61e-04 | 18 | 165 | 3 | GO:0061702 | |
| GeneOntologyCellularComponent | axolemma | 5.79e-04 | 21 | 165 | 3 | GO:0030673 | |
| GeneOntologyCellularComponent | main axon | 7.01e-04 | 89 | 165 | 5 | GO:0044304 | |
| Domain | Ig-like_fold | FLNB COL6A3 FLNC COL7A1 OBSCN LINGO2 PTPRU TGM6 KIRREL2 NOMO1 PTPRK NOMO2 PLXNA4 PKHD1 ROBO1 RIMBP3C ZPBP2 KIR2DS5 KIR3DL1 NOMO3 EPHA4 | 1.14e-06 | 706 | 165 | 21 | IPR013783 |
| Domain | - | FLNB COL6A3 FLNC COL7A1 OBSCN LINGO2 PTPRU TGM6 KIRREL2 NOMO1 PTPRK NOMO2 PLXNA4 PKHD1 ROBO1 RIMBP3C ZPBP2 KIR3DL1 NOMO3 EPHA4 | 1.70e-06 | 663 | 165 | 20 | 2.60.40.10 |
| Domain | DUF2012 | 2.69e-06 | 4 | 165 | 3 | PF09430 | |
| Domain | DUF2012 | 2.69e-06 | 4 | 165 | 3 | IPR019008 | |
| Domain | Carb-bd-like_fold | 3.67e-05 | 8 | 165 | 3 | IPR013784 | |
| Domain | FN3 | 4.01e-05 | 185 | 165 | 9 | SM00060 | |
| Domain | FIIND | 7.76e-05 | 2 | 165 | 2 | PF13553 | |
| Domain | FIIND_dom | 7.76e-05 | 2 | 165 | 2 | IPR025307 | |
| Domain | FN3_dom | 1.03e-04 | 209 | 165 | 9 | IPR003961 | |
| Domain | CarboxyPept_regulatory_dom | 1.81e-04 | 13 | 165 | 3 | IPR014766 | |
| Domain | - | 1.81e-04 | 13 | 165 | 3 | 2.60.40.1120 | |
| Domain | FN3 | 3.98e-04 | 199 | 165 | 8 | PS50853 | |
| Domain | CarboxyPept-like_regulatory | 4.20e-04 | 17 | 165 | 3 | IPR008969 | |
| Domain | DUF1908 | 4.60e-04 | 4 | 165 | 2 | PF08926 | |
| Domain | MA_Ser/Thr_Kinase_dom | 4.60e-04 | 4 | 165 | 2 | IPR015022 | |
| Domain | MAST_pre-PK_dom | 4.60e-04 | 4 | 165 | 2 | IPR023142 | |
| Domain | - | 4.60e-04 | 4 | 165 | 2 | 1.20.1480.20 | |
| Domain | Pkinase_C | 5.06e-04 | 42 | 165 | 4 | PF00433 | |
| Domain | ConA-like_dom | 7.47e-04 | 219 | 165 | 8 | IPR013320 | |
| Domain | HEAT | 8.44e-04 | 48 | 165 | 4 | PF02985 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SEMA6C ENGASE FLNC CRYBG2 KMT2B SZT2 ARHGAP26 INTS1 OBSCN LAMC3 SLC10A3 MROH1 KLHL36 PIK3CD NCAPD2 HELZ2 USP7 OGDHL PYGB PC GCN1 HTT | 2.11e-08 | 1105 | 168 | 22 | 35748872 |
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 36011023 | ||
| Pubmed | Genetic variation in the inflammasome and atopic dermatitis susceptibility. | 1.11e-07 | 3 | 168 | 3 | 23563199 | |
| Pubmed | Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes. | 1.11e-07 | 3 | 168 | 3 | 25576386 | |
| Pubmed | METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. | COL6A3 FLNC STUB1 SPTAN1 EVI5 PTPN11 NCAPD2 USP7 GCN1 SLC39A7 | 2.07e-07 | 231 | 168 | 10 | 36597993 |
| Pubmed | SHANK1 SNAPIN FLNB FGFR1OP2 ACTR8 STUB1 SPTAN1 PSMD7 ZNFX1 LRP1B TRAPPC1 STAB1 PTPRK NOMO2 TPP1 VPS35L USP7 MAST1 ROBO1 PC TOP1 EXOC4 | 2.87e-07 | 1285 | 168 | 22 | 35914814 | |
| Pubmed | 4.41e-07 | 4 | 168 | 3 | 26147384 | ||
| Pubmed | Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology. | 4.41e-07 | 4 | 168 | 3 | 31833031 | |
| Pubmed | 4.41e-07 | 4 | 168 | 3 | 9267806 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 6.71e-07 | 202 | 168 | 9 | 33005030 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | FLNB FLNC SPTAN1 NOMO1 PTPN11 NOMO2 HELZ2 USP7 GCN1 NOMO3 HTT | 1.03e-06 | 344 | 168 | 11 | 30333137 |
| Pubmed | SHANK1 TPP2 FLNB FLNC DNAJC13 PDE4D ARHGAP26 SPTAN1 ZNFX1 TRAPPC1 HSPA12A PLXNA4 USP7 MAST1 OGDHL PYGB LRRC7 FH PC TOP1 SLC39A7 EXOC4 | 1.71e-06 | 1431 | 168 | 22 | 37142655 | |
| Pubmed | Polymorphisms in inflammasome' genes and susceptibility to HIV-1 infection. | 2.19e-06 | 6 | 168 | 3 | 22227487 | |
| Pubmed | SHANK1 FLNB FGFR1OP2 LETMD1 SPTAN1 PSMD7 ZNFX1 TRIM29 LRP1B HSPA12A VIPAS39 CNTNAP2 USP7 PYGB LRRC7 PC GCN1 SLC39A7 NOS1AP | 2.88e-06 | 1139 | 168 | 19 | 36417873 | |
| Pubmed | 2.95e-06 | 21 | 168 | 4 | 36332009 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | FLNB SIN3B FAT4 APPBP2 KMT2B ANK1 CENPE INTS1 OBSCN PIDD1 RNF213 ARHGAP9 PLXNA4 PKHD1 LRRC7 | 3.22e-06 | 736 | 168 | 15 | 29676528 |
| Pubmed | TPP2 DNAJC13 SPTAN1 RNF213 PSMD7 SIX4 PTPRU RBM20 HSPA12A PTPN11 VIPAS39 PTPRK USP7 ROBO1 PC GCN1 NEURL4 NOS1AP | 3.63e-06 | 1049 | 168 | 18 | 27880917 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | FLNB FLNC PDE4D SPTAN1 OBSCN PTPN11 MROH1 CNTNAP2 ANKRD17 FH GCN1 NEURL4 EXOC4 | 4.02e-06 | 564 | 168 | 13 | 21565611 |
| Pubmed | 4.49e-06 | 191 | 168 | 8 | 33762435 | ||
| Pubmed | Nicalin and its binding partner Nomo are novel Nodal signaling antagonists. | 6.09e-06 | 8 | 168 | 3 | 15257293 | |
| Pubmed | Substrate-driven assembly of a translocon for multipass membrane proteins. | 9.10e-06 | 9 | 168 | 3 | 36261522 | |
| Pubmed | Pih1d3 is required for cytoplasmic preassembly of axonemal dynein in mouse sperm. | 1.78e-05 | 11 | 168 | 3 | 24421334 | |
| Pubmed | An ER translocon for multi-pass membrane protein biogenesis. | 1.78e-05 | 11 | 168 | 3 | 32820719 | |
| Pubmed | 1.78e-05 | 11 | 168 | 3 | 31999304 | ||
| Pubmed | TPP2 FLNB FLNC SPTAN1 INTS1 NCAPD2 HELZ2 USP7 ANKRD17 PYGB FH GCN1 TOP1 | 1.90e-05 | 653 | 168 | 13 | 22586326 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 19002483 | ||
| Pubmed | CARD8 and NLRP1 undergo autoproteolytic processing through a ZU5-like domain. | 2.32e-05 | 2 | 168 | 2 | 22087307 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 29850521 | ||
| Pubmed | The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer's disease. | 2.32e-05 | 2 | 168 | 2 | 26939933 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 17164409 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 30816317 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 20370570 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 24098386 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 18029446 | ||
| Pubmed | NLRP1 and NLRP3 inflammasomes mediate LPS/ATP‑induced pyroptosis in knee osteoarthritis. | 2.32e-05 | 2 | 168 | 2 | 29393464 | |
| Pubmed | Interaction of the inflammasome genes CARD8 and NLRP3 in abdominal aortic aneurysms. | 2.32e-05 | 2 | 168 | 2 | 21621776 | |
| Pubmed | Tripping the wire: sensing of viral protease activity by CARD8 and NLRP1 inflammasomes. | 2.32e-05 | 2 | 168 | 2 | 37311351 | |
| Pubmed | Obscurin is a ligand for small ankyrin 1 in skeletal muscle. | 2.32e-05 | 2 | 168 | 2 | 12631729 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 34162771 | ||
| Pubmed | A 3'UTR SNP in NLRP3 gene is associated with susceptibility to HIV-1 infection. | 2.32e-05 | 2 | 168 | 2 | 20502346 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 17442855 | ||
| Pubmed | A novel human actin-binding protein homologue that binds to platelet glycoprotein Ibalpha. | 2.32e-05 | 2 | 168 | 2 | 9694715 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 19120479 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 34587665 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 28185410 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 34152098 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 18263599 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 17720975 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 36649710 | ||
| Pubmed | Protein folding stress potentiates NLRP1 and CARD8 inflammasome activation. | 2.32e-05 | 2 | 168 | 2 | 36649711 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 19223160 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 24517500 | ||
| Pubmed | Inflammasome: Its role in traumatic brain and spinal cord injury. | 2.32e-05 | 2 | 168 | 2 | 29150951 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 35776169 | ||
| Pubmed | Neuroinflammation in Alzheimer's Disease: Focus on NLRP1 and NLRP3 Inflammasomes. | 2.32e-05 | 2 | 168 | 2 | 34530705 | |
| Pubmed | A novel FLNC frameshift and an OBSCN variant in a family with distal muscular dystrophy. | 2.32e-05 | 2 | 168 | 2 | 29073160 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 2022189 | ||
| Pubmed | Conformational Changes in the Cytoplasmic Region of KIR3DL1 upon Interaction with SHP-2. | 2.32e-05 | 2 | 168 | 2 | 30773397 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 21245836 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 16741999 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 31412620 | ||
| Pubmed | The limits of promiscuity: isoform-specific dimerization of filamins. | 2.32e-05 | 2 | 168 | 2 | 12525170 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 29230505 | ||
| Pubmed | Deubiquitinase USP7 contributes to the pathogenicity of spinal and bulbar muscular atrophy. | 2.32e-05 | 2 | 168 | 2 | 33170804 | |
| Pubmed | Structural basis for distinct inflammasome complex assembly by human NLRP1 and CARD8. | 2.32e-05 | 2 | 168 | 2 | 33420028 | |
| Pubmed | Mechanism of filament formation in UPA-promoted CARD8 and NLRP1 inflammasomes. | 2.32e-05 | 2 | 168 | 2 | 33420033 | |
| Pubmed | Evidence of interaction of CARD8 rs2043211 with NALP3 rs35829419 in Crohn's disease. | 2.32e-05 | 2 | 168 | 2 | 20182451 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 32689633 | ||
| Pubmed | The cyclopentenone prostaglandin 15d-PGJ2 inhibits the NLRP1 and NLRP3 inflammasomes. | 2.32e-05 | 2 | 168 | 2 | 25681332 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 24334646 | ||
| Pubmed | Phosphorylation of ankyrin down-regulates its cooperative interaction with spectrin and protein 3. | 2.32e-05 | 2 | 168 | 2 | 2970468 | |
| Pubmed | Dual role for inflammasome sensors NLRP1 and NLRP3 in murine resistance to Toxoplasma gondii. | 2.32e-05 | 2 | 168 | 2 | 24549849 | |
| Pubmed | Loss-of-function CARD8 mutation causes NLRP3 inflammasome activation and Crohn's disease. | 2.32e-05 | 2 | 168 | 2 | 29408806 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 22128899 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 29528779 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 24008734 | ||
| Pubmed | Genetic variation in inflammasome genes is associated with outcome in bacterial meningitis. | 2.32e-05 | 2 | 168 | 2 | 23053059 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 31529732 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 36835594 | ||
| Pubmed | Inflammasome polymorphisms confer susceptibility to sporadic malignant melanoma. | 2.32e-05 | 2 | 168 | 2 | 22524199 | |
| Pubmed | Association of CARD8 Activating Polymorphism With Bone Erosion in Cholesteatoma Patients. | 2.32e-05 | 2 | 168 | 2 | 32396255 | |
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 37712526 | ||
| Pubmed | 2.32e-05 | 2 | 168 | 2 | 31663353 | ||
| Pubmed | 2.55e-05 | 397 | 168 | 10 | 21319273 | ||
| Pubmed | SIN3B ARHGEF28 DYNC2H1 RNF213 ZNF623 ATP10A HELZ2 DDHD2 NEURL4 MAST3 EXOC4 | 3.05e-05 | 493 | 168 | 11 | 15368895 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 3.73e-05 | 256 | 168 | 8 | 33397691 | |
| Pubmed | FLNB SIN3B DNAJC13 KMT2B RBM20 ANKRD17 PC GCN1 SLC39A7 EXOC4 | 3.94e-05 | 418 | 168 | 10 | 34709266 | |
| Pubmed | DNAJC13 STUB1 SZT2 DYNC2H1 PSMD7 PARS2 NOMO1 NOMO2 NCAPD2 TIMM29 PC NOMO3 | 4.22e-05 | 606 | 168 | 12 | 36538041 | |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | DNAJC13 GALC PDE4D ARHGAP26 CAPG PSMD7 TRIM29 ZNF71 MRPS2 HELZ2 USP7 ANKRD17 GCN1 | 6.13e-05 | 732 | 168 | 13 | 34732716 |
| Pubmed | 6.13e-05 | 44 | 168 | 4 | 20200978 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 28007908 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 11509555 | ||
| Pubmed | Language development and disorders: Possible genes and environment interactions. | 6.94e-05 | 3 | 168 | 2 | 30077386 | |
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 21060114 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 12393796 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 31694740 | ||
| Pubmed | Pathogenic variants of DYNC2H1, KIAA0556, and PTPN11 associated with hypothalamic hamartoma. | 6.94e-05 | 3 | 168 | 2 | 31197031 | |
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 24553178 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 19319132 | ||
| Pubmed | 6.94e-05 | 3 | 168 | 2 | 11153914 | ||
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 2.95e-04 | 50 | 116 | 4 | 721 | |
| GeneFamily | Fibronectin type III domain containing | 5.82e-04 | 160 | 116 | 6 | 555 | |
| Coexpression | ZHONG_PFC_C3_ASTROCYTE | SEMA6C SIN3B TMEM151B OBSCN PTPRU PLXNA4 USP7 MAST1 ZFTA LRRC7 GCN1 UNC79 MAST3 | 1.29e-06 | 389 | 166 | 13 | M39102 |
| Coexpression | GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP | 5.30e-06 | 199 | 166 | 9 | M4444 | |
| Coexpression | IBRAHIM_NRF2_DOWN | 1.23e-05 | 168 | 166 | 8 | M42513 | |
| Coexpression | ZHONG_PFC_C1_NEUROD1_POS_EXCITATORY_NEURON | 2.08e-05 | 26 | 166 | 4 | M39088 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP | 2.47e-05 | 185 | 166 | 8 | MM1115 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | PDE4D ANK1 LRP1B ADCY2 PTPRK PIK3CD CNTNAP2 PLXNA4 MAST1 OGDHL ROBO1 LRRC7 UNC79 PCDH9 CCDC144A | 4.37e-05 | 703 | 166 | 15 | M39070 |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.64e-09 | 200 | 167 | 10 | 7e51715525fdb001b7042b2bfcb9de81ecb5e4ee | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.91e-08 | 200 | 167 | 9 | 75649534a98bc738fca62d071de0978dc61eb24f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.89e-07 | 184 | 167 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.89e-07 | 184 | 167 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.89e-07 | 184 | 167 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 5.52e-07 | 187 | 167 | 8 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | COVID-19-kidney-DCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.75e-07 | 188 | 167 | 8 | 1d56cd409793f05cca20757ab26e91f1a1ee67b5 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.99e-07 | 189 | 167 | 8 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.18e-07 | 197 | 167 | 8 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.83e-07 | 199 | 167 | 8 | a95aa72387c9558e0316898eaa9df4de8932af1b | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.29e-06 | 167 | 167 | 7 | 961e722442d786ab15d1e490941d2be265a9057a | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.29e-06 | 167 | 167 | 7 | 3760efc35d4e7e9c2da1a20f9795ddea397e2206 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.65e-06 | 176 | 167 | 7 | 0710689e66deba179b0a8038cdd56b4834984f12 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.01e-06 | 178 | 167 | 7 | 6f61490d79cd1727ed2d5cc673823dd4efdafac1 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.20e-06 | 179 | 167 | 7 | 97ba67a856680f24846244c0b92c886cc0e79537 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.39e-06 | 180 | 167 | 7 | b6efdb4d319ef6f87f559acd974e5a71b06a2322 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.59e-06 | 181 | 167 | 7 | 4ea02344e1996f264dd5e14f3b19c8782ce41699 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3_VIP_CBLN1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.59e-06 | 181 | 167 | 7 | 7846c7b33d1b89364c5a704edaa86520db731c89 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.80e-06 | 182 | 167 | 7 | 35b2a5625323bf0917214d3b82fafc4a8f5e75ff | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.23e-06 | 184 | 167 | 7 | 9a185e6ea86bbfbb48bfe88650a8c05ceba78d7f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.92e-06 | 187 | 167 | 7 | 85f1678338a47d91e296f0620d4887f057eb7e70 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.92e-06 | 187 | 167 | 7 | 7b2cd0c618ed081223343f3bec2244c8723c9a31 | |
| ToppCell | COVID-19-kidney|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.92e-06 | 187 | 167 | 7 | d23aae9419d460b78b1d4092d7acd9108a47cfbe | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.92e-06 | 187 | 167 | 7 | f124d2c699b717b7c02a1a70493f515b83dc2f4c | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.95e-06 | 191 | 167 | 7 | b9ae5af426e7a1f2652a47700bb168371bd2dec6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.22e-06 | 192 | 167 | 7 | 3abee376c37c3646da33ac381aa63d50a01607a6 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 8.22e-06 | 192 | 167 | 7 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | Control-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 8.22e-06 | 192 | 167 | 7 | 7e89b9125e8b85f6be85eeccef5c8644647ab0e1 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.50e-06 | 193 | 167 | 7 | 3ed46f5a7419ec4eddbd0df0d9b5f53aa486198b | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CBLN1-L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.07e-05 | 200 | 167 | 7 | 2086024ce808b8796ed508a229b098eb02f8828a | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CBLN1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.07e-05 | 200 | 167 | 7 | 35951db6a4f442ac9e13f1b8cc5b4a33481f92c8 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CCDC184-L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.07e-05 | 200 | 167 | 7 | 140aff451cd58e1d544ee668e49e37e577f6f068 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CCDC184|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.07e-05 | 200 | 167 | 7 | 85bfa7f4dd07a4d4a88330e88f5886fd1ecfdeeb | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-CPNs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.07e-05 | 200 | 167 | 7 | 71cbefbef4ae5bbb5f6e419914f4b3b3b5a5f9e3 | |
| ToppCell | LA-15._Ventricular_Cardiomyocyte_III|LA / Chamber and Cluster_Paper | 1.96e-05 | 147 | 167 | 6 | 8970eb6b82589f39439c61a57d999661ec8342de | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-05 | 160 | 167 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-05 | 160 | 167 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | 356C-Myeloid-Dendritic-pDC|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 3.51e-05 | 163 | 167 | 6 | ae9c5eb19657ea94b7f2357cbc8679acd697b8fe | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Cajal-Retzius|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.51e-05 | 163 | 167 | 6 | c1484e4de8b10e2f5fb14a7c02b2a015ffe0305e | |
| ToppCell | 356C-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.63e-05 | 164 | 167 | 6 | fed26f4ac36a2b0722bc7b9f91659c5e0cf4d53a | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 4.02e-05 | 167 | 167 | 6 | 9efb9511a211d0824bb97f82c1a5860c43d2138f | |
| ToppCell | Cerebellum-Neuronal-Inhibitory|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 4.02e-05 | 167 | 167 | 6 | 904c613aac3f9919a432b110bb1dcc832b5aec0a | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-OPC_related|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 4.29e-05 | 169 | 167 | 6 | 29db25e7c5f31d98a08a35d7ec5ade203242bc50 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-OPC_related-Oligodendrocyte/OPC|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 4.29e-05 | 169 | 167 | 6 | b1611e61f635f8f9b87250e026ad30999cbee041 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-05 | 169 | 167 | 6 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | NS-critical-LOC-Lymphoid-NK|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.58e-05 | 171 | 167 | 6 | adda76991d9b150bb8ccf3989b7cbbf41843cf0b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.05e-05 | 174 | 167 | 6 | 9cc7251661ea2b1565eef1dfb8cf6dec3ade13d4 | |
| ToppCell | RSV-Healthy-1|Healthy / Virus stimulation, Condition and Cluster | 5.21e-05 | 175 | 167 | 6 | ff3a27f512a3a710ebc863b7b75cce8167d5440b | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D175|Adult / Lineage, Cell type, age group and donor | 5.21e-05 | 175 | 167 | 6 | 0a65ddfa8c2e8efb5b5338cf07661cb78157a23c | |
| ToppCell | RSV-Healthy-1|RSV / Virus stimulation, Condition and Cluster | 5.21e-05 | 175 | 167 | 6 | ca52b99b03535a5b3a2751d6981708dc5b255b91 | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 5.55e-05 | 177 | 167 | 6 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 5.91e-05 | 179 | 167 | 6 | af35ef8a7768cee0c2af0590e5bec35cee6a4714 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L5-6_THEMIS_TMEM233|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.91e-05 | 179 | 167 | 6 | 747a32460b257fffca30527b56a74720eb9c12e4 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.91e-05 | 179 | 167 | 6 | 1ac79c82c52fa95bb4e170ab20fec0f648db2134 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.91e-05 | 179 | 167 | 6 | 065a50952e8703fa07767beb6b73a090bf378ca6 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.91e-05 | 179 | 167 | 6 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.28e-05 | 181 | 167 | 6 | 9de2f2cc5f02e0ca599c9e0d2cb1e1e4b5aac112 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.48e-05 | 182 | 167 | 6 | cc6f9d606a4f8717dc44928ceec2a257636043fd | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.48e-05 | 182 | 167 | 6 | 7dc61e901428cea04f00ebb0939a44d21a6145c6 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.48e-05 | 182 | 167 | 6 | 39f9b3eb22293cc27c6e175702c77d1eeb24fdc9 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 6.48e-05 | 182 | 167 | 6 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.48e-05 | 182 | 167 | 6 | 420a8fd30543e37a66ba0786215d056d308660d0 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.09e-05 | 185 | 167 | 6 | 027020754dbf71b0034791f9a34ae795e3b85f81 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.09e-05 | 185 | 167 | 6 | 87151ab95530e70d61328b336518df58db584acb | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.09e-05 | 185 | 167 | 6 | 08fad1e3c3cc5f1c3eb6629a49c094b628e75a92 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.09e-05 | 185 | 167 | 6 | cefd81adb480c027545a5c78dcd05669783717f4 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.30e-05 | 186 | 167 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.30e-05 | 186 | 167 | 6 | 8915436d09775f2828a7678af203b1082b36e21c | |
| ToppCell | Substantia_nigra-Neuronal|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.30e-05 | 186 | 167 | 6 | 3f889083fcffe516388e9b03a5e23af2010ced33 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-Granular_Neuron_CB_Gabra6|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.30e-05 | 186 | 167 | 6 | d6c8ce2a32c218dcc63d861cc247152430ed3c8c | |
| ToppCell | LPS_only-Unknown-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.33e-05 | 115 | 167 | 5 | ad5298c2ad8bf94fa13c2e50b0799e929473ef59 | |
| ToppCell | LPS_only-Unknown|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.33e-05 | 115 | 167 | 5 | 7a733f6987b40ec497a03734b79ed5355ad3a2fc | |
| ToppCell | LPS_only-Unknown-Endothelial-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.33e-05 | 115 | 167 | 5 | c67145d3cd9243994a141749b426ff2a6dcc8d93 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 7.52e-05 | 187 | 167 | 6 | f3e37c18ac6471c7992609bbddfa4975571c815c | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.52e-05 | 187 | 167 | 6 | e93cad16a087d1443cbf4e1690dc1b35d7a84c41 | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 7.75e-05 | 188 | 167 | 6 | 6f8946d4710f6e32c937213f99b790b098b8819c | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 7.75e-05 | 188 | 167 | 6 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | ASK454-Endothelial-Lymphatic|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.98e-05 | 189 | 167 | 6 | 316c857dec9383823e09f966bca62d52d933b141 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.98e-05 | 189 | 167 | 6 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.45e-05 | 191 | 167 | 6 | 3e828cffa24ded19f591a7ed6c1fe88ad57fdcac | |
| ToppCell | COPD-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 8.45e-05 | 191 | 167 | 6 | ef16ad1c1cd2c0c0377957398c98775b62a81754 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.45e-05 | 191 | 167 | 6 | 9032aa974aa1b7b1095b8d1b58dcb087358a5001 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.45e-05 | 191 | 167 | 6 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.45e-05 | 191 | 167 | 6 | 5717809a1476c20f65bce722c5a57cff92ee0d7a | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.70e-05 | 192 | 167 | 6 | 25378b5e4b0cea8415ff125783511fc25a56fc00 | |
| ToppCell | COVID-19-kidney-CNT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.70e-05 | 192 | 167 | 6 | 760c6b9628de9693034b00c5025c5c4df94bb2e8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.70e-05 | 192 | 167 | 6 | 6a252e298f8a454623fa9c1c893a7a45a886d694 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 8.70e-05 | 192 | 167 | 6 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.95e-05 | 193 | 167 | 6 | 826b8dd801298b3e0cd76232feae5a14026b8806 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.95e-05 | 193 | 167 | 6 | d1445b8bf2bab36e1a326ddb2a528151db016c7d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.95e-05 | 193 | 167 | 6 | 010717ca052b6c8a525a43aaeffddea0d1113e63 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.95e-05 | 193 | 167 | 6 | 87d3a577d37fb0cb4b6313c596310de452bc3872 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.95e-05 | 193 | 167 | 6 | d485634c564b268e344b6a2863c26f6adaec9e38 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_proliferating|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.95e-05 | 193 | 167 | 6 | 5f0eba7b1440beb891d94a288f7f18a4e13c3a88 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.95e-05 | 193 | 167 | 6 | e5016959f24370579a8770787e96869f264cf7b3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.95e-05 | 193 | 167 | 6 | 0b328f725f6feba263783eaca60c142e80df90f3 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 8.95e-05 | 193 | 167 | 6 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 8.95e-05 | 193 | 167 | 6 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.95e-05 | 193 | 167 | 6 | 658c2b30a4d806c5ce78ea4392fe8eb86b8d1e99 | |
| ToppCell | B_cells-ISG-high_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 9.47e-05 | 195 | 167 | 6 | b64d9e1a8834401b4dc501566546647754ae21fc | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A | COL7A1 CRYBG2 ARHGAP26 SPTAN1 NLRP1 ARL4D PHKG2 PIK3CD CNTNAP2 PCDH9 NOS1AP ZNF574 | 9.88e-09 | 182 | 166 | 12 | 7503_UP |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 8.95e-05 | 3 | 162 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 8.95e-05 | 3 | 162 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | waist circumference | TRIB2 ARHGAP26 GRB14 LINGO2 SLC39A13 DNAAF3 PTPRK KLHL36 CNTNAP2 PKHD1 | 1.38e-04 | 429 | 162 | 10 | EFO_0004342 |
| Disease | JUVENILE MYELOMONOCYTIC LEUKEMIA | 1.78e-04 | 4 | 162 | 2 | 607785 | |
| Disease | Juvenile myelomonocytic leukemia | 1.78e-04 | 4 | 162 | 2 | cv:C0349639 | |
| Disease | Metastatic melanoma | 2.24e-04 | 54 | 162 | 4 | C0278883 | |
| Disease | Malignant neoplasm of breast | DPAGT1 FLNB COL7A1 ANK1 DYNC2H1 SPTAN1 OBSCN SIX4 TRIM29 PKDREJ ROBO1 LRRC7 FGD5 DNAH9 TOP1 VPS13B | 2.95e-04 | 1074 | 162 | 16 | C0006142 |
| Disease | Myelomonocytic leukemia | 2.96e-04 | 5 | 162 | 2 | C0027019 | |
| Disease | hypertension | 3.10e-04 | 307 | 162 | 8 | EFO_0000537 | |
| Disease | cognitive function measurement | EFCAB5 PDE4D CYP2D7 SZT2 ARHGAP9 LAMC3 RFX6 LINGO2 LRP1B ADCY2 STAB1 SRGAP1 PLXNA4 PKHD1 MAST1 LRRC7 KIF3C CDH9 EXOC4 | 3.48e-04 | 1434 | 162 | 19 | EFO_0008354 |
| Disease | neutropenia, response to metamizole, Drug-induced agranulocytosis | 4.43e-04 | 6 | 162 | 2 | EFO_0010971, HP_0012235, MONDO_0001475 | |
| Disease | alcohol consumption measurement | RPS6KA5 TNFSF13 LAMC3 RFX6 LINGO2 DPP3 GDF1 AK8 SLC39A13 PIGQ PHKG2 PTPRK PLXNA4 PKHD1 HTT EPHA4 ZNF574 | 5.03e-04 | 1242 | 162 | 17 | EFO_0007878 |
| Disease | juvenile myelomonocytic leukemia (is_implicated_in) | 6.18e-04 | 7 | 162 | 2 | DOID:0050458 (is_implicated_in) | |
| Disease | cesarean section, Self-injurious behavior | 7.17e-04 | 32 | 162 | 3 | EFO_0009636, HP_0100716 | |
| Disease | stem Cell Growth Factor beta measurement | 7.86e-04 | 75 | 162 | 4 | EFO_0008292 | |
| Disease | melanoma (implicated_via_orthology) | 8.21e-04 | 8 | 162 | 2 | DOID:1909 (implicated_via_orthology) | |
| Disease | Ataxias, Hereditary | 8.21e-04 | 8 | 162 | 2 | C0004138 | |
| Disease | Disproportionate short stature | 8.68e-04 | 77 | 162 | 4 | C0878659 | |
| Disease | Kartagener Syndrome | 9.34e-04 | 35 | 162 | 3 | C0022521 | |
| Disease | Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus | 9.34e-04 | 35 | 162 | 3 | C4551906 | |
| Disease | Polynesian Bronchiectasis | 9.34e-04 | 35 | 162 | 3 | C4317124 | |
| Disease | choroid plexus volume measurement | 1.05e-03 | 9 | 162 | 2 | EFO_0010293 | |
| Disease | lymphocyte count | DPAGT1 FLNB TRIB2 PDE4D ANK1 GRB14 HIF3A PREX2 ZNF71 SCML4 LMAN1L PIK3CD USP7 ZPBP2 DDHD2 NEURL4 HTT CDK6 | 1.18e-03 | 1464 | 162 | 18 | EFO_0004587 |
| Disease | neurodegenerative disease (implicated_via_orthology) | 1.26e-03 | 145 | 162 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | promotilin measurement | 1.31e-03 | 10 | 162 | 2 | EFO_0801930 | |
| Disease | telomere length | 1.78e-03 | 313 | 162 | 7 | EFO_0004505 | |
| Disease | Colorectal Carcinoma | SHANK1 DPAGT1 FLNC COL7A1 ZNF155 TNFSF13 OBSCN PTPRU PREX2 PKHD1 EXOC4 | 1.79e-03 | 702 | 162 | 11 | C0009402 |
| Disease | left ventricular systolic function measurement | 1.82e-03 | 44 | 162 | 3 | EFO_0008206 | |
| Disease | diffusing capacity of the lung for carbon monoxide | 1.96e-03 | 96 | 162 | 4 | EFO_0009369 | |
| Disease | Primary Ciliary Dyskinesia | 2.21e-03 | 47 | 162 | 3 | C4551720 | |
| Disease | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | 2.53e-03 | 170 | 162 | 5 | EFO_0000685, EFO_0007791, EFO_0007837 | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 2.61e-03 | 14 | 162 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | lysophosphatidylcholine 15:0 measurement | 2.61e-03 | 14 | 162 | 2 | EFO_0020941 | |
| Disease | trauma exposure measurement | 2.66e-03 | 172 | 162 | 5 | EFO_0010703 | |
| Disease | Oral ulcer | 2.91e-03 | 107 | 162 | 4 | HP_0000155 | |
| Disease | level of C-X-C motif chemokine 3 in blood serum | 3.00e-03 | 15 | 162 | 2 | OBA_2041208 | |
| Disease | Situs ambiguus | 3.00e-03 | 15 | 162 | 2 | C0266642 | |
| Disease | African Burkitt's lymphoma | 3.00e-03 | 15 | 162 | 2 | C0343640 | |
| Disease | Autosomal recessive primary microcephaly | 3.00e-03 | 15 | 162 | 2 | cv:C3711387 | |
| Disease | RASopathy | 3.00e-03 | 15 | 162 | 2 | cv:C5555857 | |
| Disease | Burkitt Leukemia | 3.00e-03 | 15 | 162 | 2 | C4721444 | |
| Disease | Ciliopathies | 3.22e-03 | 110 | 162 | 4 | C4277690 | |
| Disease | asthma, response to diisocyanate | 3.28e-03 | 261 | 162 | 6 | EFO_0006995, MONDO_0004979 | |
| Disease | p-cresol sulfate measurement | 3.42e-03 | 16 | 162 | 2 | EFO_0010998 | |
| Disease | optic cup area measurement | 3.64e-03 | 56 | 162 | 3 | EFO_0006940 | |
| Disease | cancer (implicated_via_orthology) | 3.73e-03 | 268 | 162 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | response to radiation, Urinary retention | 3.86e-03 | 17 | 162 | 2 | GO_0009314, HP_0000016 | |
| Disease | plasma beta-amyloid 1-40 measurement | 3.86e-03 | 17 | 162 | 2 | EFO_0005659 | |
| Disease | Dystonia, Limb | 3.86e-03 | 17 | 162 | 2 | C0751093 | |
| Disease | Dystonia, Diurnal | 3.86e-03 | 17 | 162 | 2 | C0393610 | |
| Disease | urate measurement | COL7A1 DNAJC13 TRIM29 STAB1 PTPN11 PKHD1 PYGB DDHD2 PC TOP1 MAST3 EPHA4 | 4.00e-03 | 895 | 162 | 12 | EFO_0004531 |
| Disease | neuroticism measurement, cognitive function measurement | 4.19e-03 | 566 | 162 | 9 | EFO_0007660, EFO_0008354 | |
| Disease | Dystonia, Paroxysmal | 4.33e-03 | 18 | 162 | 2 | C0393588 | |
| Disease | response to mepolizumab, Glucocorticoid use measurement | 4.33e-03 | 18 | 162 | 2 | EFO_0008459, EFO_0009942 | |
| Disease | aspartate aminotransferase measurement | FLNB DNAJC13 OBSCN RNF213 ARHGAP9 NLRP3 HSPA12A PTPN11 CNTNAP2 ROBO1 GCN1 CDK6 | 4.33e-03 | 904 | 162 | 12 | EFO_0004736 |
| Disease | amino acid measurement | FAT4 PDE4D ARHGEF28 ZNF596 GRB14 ARHGAP9 LINGO2 TGM6 KIF3C HTT | 4.39e-03 | 678 | 162 | 10 | EFO_0005134 |
| Disease | Juvenile Myelomonocytic Leukemia | 4.82e-03 | 19 | 162 | 2 | C0349639 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PLLQGNVRHSEHEFL | 431 | P54793 | |
| LPHFQALHVVVIGLD | 16 | P49703 | |
| DISGLQDHEFQIRHP | 356 | Q9H981 | |
| PLHIAAREGHVETVL | 506 | P16157 | |
| EPILQRRGHVESHDF | 4116 | Q6V0I7 | |
| FAVLHGHIPVVQLLL | 656 | A6QL63 | |
| HAERAIGIITHILPE | 356 | Q92624 | |
| EVAVLRHLETFEHPN | 61 | Q00534 | |
| RHLETFEHPNVVRLF | 66 | Q00534 | |
| QPQHDVRLEDLGELH | 71 | Q8IYA2 | |
| HPIIIVGDDRGHIIS | 641 | Q9UI46 | |
| HVIILGDLNTAHRPI | 191 | Q9UBZ4 | |
| HLAVVELLLAHGADP | 676 | O75179 | |
| ERLHDQVSVELPHLG | 716 | O60312 | |
| VEGHRFPAEIHVVHL | 241 | Q16790 | |
| VRPLQAHELNDFHGV | 391 | Q5T481 | |
| IERALPHHRVIEVGN | 1026 | P69849 | |
| HLAQIARPALFDQHV | 391 | Q8HWS3 | |
| HLPSVAHLEDFQGLI | 1536 | A6NJZ7 | |
| LSGFEDVHLEPHLLI | 1246 | Q8N1W1 | |
| IERALPHHRVIEVGN | 1026 | Q5JPE7 | |
| PLEVEHVVGQGVLHR | 271 | Q6N063 | |
| AHARQVLENIHFPLI | 226 | Q8N4N3 | |
| HAFEIPDNVRPGHLI | 451 | Q6ZMT4 | |
| SKQGLLHPHRIDIFE | 4111 | Q9NZR2 | |
| IQRGTHPAIHDILAL | 221 | Q6P1Q0 | |
| IPHFCGVQLDQRHLV | 96 | Q6ZVW7 | |
| ELLQPHVFRSEHQGA | 1916 | Q8N201 | |
| IVGVPLELEQSTHRH | 816 | Q96NW7 | |
| PVGIEHHFLELDHIL | 416 | Q9HAT1 | |
| RIFILAHFPHQVLAG | 161 | Q9BUM1 | |
| HVEELGVAGNIVRHI | 91 | P27539 | |
| HLLQGDFPREIHFHV | 271 | Q6UWP7 | |
| QFDHPNIIHLEGVVT | 676 | P54764 | |
| IHIPIFHGRIFQESF | 66 | P43629 | |
| LRGVIPNAFEHIFTH | 116 | O14782 | |
| PHHEFVALIGALLAI | 91 | Q9H3H5 | |
| HIGISFIPREVGEHL | 1961 | O75369 | |
| VLHGVPRDLDQAHLL | 351 | Q96MA6 | |
| PRIITENGDHHVVQL | 621 | Q9HCM2 | |
| ILDGPELHDVLEIHF | 241 | P80217 | |
| IRGHHVAQLDPLGIL | 126 | Q9ULD0 | |
| GLAPLHIQLVDAHEA | 141 | P09131 | |
| HHVIQELPLDNTFVG | 961 | Q9HC56 | |
| IHDVDHPGVSNQFLI | 501 | Q08499 | |
| VEAVHLPHFVALQGG | 1161 | Q9C000 | |
| PFDGIHIVNHLIGDD | 721 | O60447 | |
| IARIAQHLEHIDPTA | 486 | Q32MH5 | |
| GEGVFQSDLLLPHIH | 186 | Q6ZNL6 | |
| IRFIPHENGVHSIDV | 2466 | Q14315 | |
| IERALPHHRVIEVGN | 1026 | Q15155 | |
| LQIDHLVFVVHGIGP | 211 | O94830 | |
| DQVLELHPGAQRLHI | 131 | Q8WVB3 | |
| HGQHLERLARELFPD | 216 | B2RXH2 | |
| PSFDVQVGLHELLGH | 441 | Q9NY33 | |
| ELHIVGAQLRTIEPH | 301 | Q7L985 | |
| IPFLQQEVHEGTLVH | 391 | Q92616 | |
| GIHHDAVIFLAEQLP | 2466 | Q9UMN6 | |
| HDVGVVHRDLKPENL | 536 | O75582 | |
| VDLTVHQIRLPEGHL | 321 | O43301 | |
| NILPFDHTRVVLHDG | 281 | Q06124 | |
| LEHLRVSALVPFHNL | 951 | Q8NDA8 | |
| LRQVAGHPHIITLID | 81 | P15735 | |
| PLADGVLSFIHHQII | 211 | Q9Y2H9 | |
| FNHTLRLIGEHIDGV | 66 | Q14953 | |
| HTGQLHPAVRVADLL | 866 | Q92729 | |
| PAHFIGRLRHQESIE | 3361 | Q5VST9 | |
| LDASRHILEAPQHGL | 146 | Q9NVK5 | |
| HVLERIHPLETEQAG | 3101 | Q8NCM8 | |
| DPHEINIFLPHEIRF | 1126 | A4FU69 | |
| HPLLRFIQEIEHALG | 501 | Q96A65 | |
| LENVLPAHVAEHFLA | 856 | Q08462 | |
| FPIDDRVQSHILHLE | 561 | P07199 | |
| VVIHLLGDEDPRVRH | 911 | P42858 | |
| KLHDRGAQVIHPQEF | 216 | Q8N9W5 | |
| DIEEHLQRVGHFDPV | 256 | Q9UNE7 | |
| HIAAAIEVHEVLLPG | 196 | P07954 | |
| VGLEHLRVNHFVPEA | 1721 | P12111 | |
| LQPVLQVGEHDLHFV | 1341 | Q8N1P7 | |
| AEIHLPHFISLQAGE | 246 | Q9Y2G2 | |
| QPQHDVRLEDLGELH | 71 | Q3MJ40 | |
| DHDPGRHLFVGQLIQ | 226 | Q9Y2A9 | |
| QELALSEGALPRHLH | 601 | O75165 | |
| LADGVLGFIHHQIVE | 206 | O60307 | |
| AANGQHDLHIRPVEL | 81 | Q6UWL6 | |
| LFEHLPHIGVERTIE | 151 | Q14449 | |
| AVHLNTLLGERPVQH | 81 | P40121 | |
| AAILHVADHVFLPQL | 121 | Q02388 | |
| NSDGVVRHELQHPII | 141 | Q9UHC6 | |
| HLSAQEIQPLFGEHR | 426 | Q8NFI3 | |
| AALAEAQDIHVHLIP | 301 | Q9NYC9 | |
| QPQHDVRLEDLGELH | 71 | A2RUR9 | |
| LRIPLHNEDAFQHGI | 16 | O75052 | |
| PVIFGHVQGHERSLL | 2466 | Q9BYK8 | |
| EDPGEHHFTLRQVLN | 521 | P54803 | |
| DSQQFHLVPVHLDRV | 141 | Q9H1E1 | |
| HGVGLVLRVEQQPHL | 466 | P51172 | |
| LHEIPHEVGDFAILL | 256 | Q96H72 | |
| HIPVFIRILDINDHA | 471 | Q9ULB4 | |
| DHLGVIPRAIHDIFQ | 101 | Q02224 | |
| LRPHATDDFNHGVVL | 541 | Q96JN8 | |
| LLSHVLELQPHGVAF | 376 | Q9HB75 | |
| GQLHPAIRVADLLQH | 861 | Q15262 | |
| VIHQFFRDIPHVLAL | 171 | A6ND48 | |
| LLDHPRHVEILGFSE | 361 | Q96P20 | |
| VPQLHGEVLLDDRTH | 401 | Q7L3T8 | |
| PVGQVDRHIQLLVHG | 2151 | Q5T011 | |
| EFLRPAVQQLDSHVH | 31 | O95295 | |
| DLFPHLDDILQHVNG | 481 | Q9Y3M8 | |
| DSIHQLGFIHRDIKP | 201 | Q15208 | |
| PHLEGAAFRDHQLLE | 201 | Q14134 | |
| AQEHRGHELVPLEQE | 206 | Q96LD4 | |
| LIQGLVLDHGARHPD | 206 | Q92526 | |
| EGTIIPHHILDFLEI | 996 | Q68CR1 | |
| SGDPVFHIRLEERHQ | 196 | Q7Z6B7 | |
| DDEFLHLPAHLRVVG | 186 | Q9BSF4 | |
| FPVLIVHRQEGCLGH | 536 | Q8IW70 | |
| VHPLVLLSVVDHFNR | 11 | P51665 | |
| VELRGHTVILHAQPG | 1306 | Q6ZWJ8 | |
| DQHLRGHVIVLPDND | 1211 | Q9NTG1 | |
| QLELIGHSIFDFIHP | 121 | Q9Y2N7 | |
| RIGHLADALVPVADH | 301 | Q9BRB3 | |
| HPNLHLLFDRPEEAV | 736 | Q9UNA1 | |
| PAVHQDFVQEHRLVL | 701 | Q9UIU6 | |
| VSQLFHEHPDLIVGF | 86 | O75182 | |
| LAVRHLSLHIEPEEG | 16 | P08F94 | |
| LHTLNNIFEPHVAVR | 196 | Q9Y399 | |
| RAQFLDHEIDGSHLP | 2116 | Q9Y566 | |
| ILHHFRSIDPGLKED | 66 | Q15021 | |
| EGHLILPTFNHLVIR | 111 | Q32M92 | |
| AVIHEVQHFGDIVPL | 376 | A0A087X1C5 | |
| ILGPGNNIHFIHRDR | 181 | Q7RTV5 | |
| DEFHRDLSHILGIPQ | 656 | Q63HN8 | |
| TDLGVGPIRDVLHHI | 86 | Q9Y5R8 | |
| LRQHQRIHAGEKPFE | 381 | Q8NA42 | |
| REVGIKHQEIPFIQH | 76 | Q8TC21 | |
| VPDHPEHGVLFLVRE | 786 | Q7Z3J2 | |
| LLHEVPHEVGDFAIL | 356 | Q92504 | |
| VLPEHHEAFNRLLGD | 101 | A6NLX3 | |
| LLEPLEGDHVFRAVH | 66 | Q92519 | |
| HQALQAEIAGHEPRI | 826 | Q13813 | |
| LLEVHQLVVHAGRQP | 621 | Q6ZN55 | |
| HLDHVAALFPGDVDR | 411 | P11216 | |
| DVHFKPGQIRRHFIE | 651 | P29144 | |
| HEVQEHFPEALARLL | 536 | O00329 | |
| FRLGFHEVHILPDIN | 886 | P55017 | |
| LREPHFVQALEHGDH | 221 | Q9H3T2 | |
| ELLQHHGLVPQIEAA | 1146 | Q9NY15 | |
| NVLHIRTIPGHEFLL | 401 | Q9BRR9 | |
| HRPEEGVHLGQALLE | 426 | Q70Z35 | |
| RELGNAVLHLHNPTV | 671 | Q9Y6N7 | |
| GFHRVVEILHKNNAP | 406 | Q9H9C1 | |
| GIVHRALSPHNILLD | 111 | Q8TEA7 | |
| VRGIHLINEPVIFHA | 191 | P49638 | |
| IDPVLHNLTELRHLG | 306 | Q8TE23 | |
| HLILIGDHQQLRPSA | 1026 | Q9P2E3 | |
| IEPDLVHHLTFQARE | 2886 | Q7Z7G8 | |
| GVRHPHIVHVFEFIE | 66 | Q9BXA6 | |
| FNLDLHQRVHTGERP | 441 | Q12901 | |
| LIEHQRIHTGERPFE | 306 | O75123 | |
| PFLLRIHQGEHFREV | 1006 | Q93009 | |
| LIQHQRFHIGVKPFE | 341 | Q9NQZ8 | |
| HAQIHVAEGRSLPDL | 346 | P11498 | |
| SLRVEHINLHPELDG | 506 | P11387 | |
| QALGPHVELFRKHEI | 361 | Q8N228 | |
| ILHESHAVRLGPQEE | 546 | O95932 | |
| VFHLHQGDILSVIIP | 216 | O75888 | |
| SVEIPEHGLIHELFI | 191 | Q6X784 | |
| HLDDIRAHVLEVHPG | 296 | C9JLR9 | |
| HVADHLIVILIGFPE | 2446 | Q9P2D8 | |
| IRQAELLLPGAEFHH | 126 | O14773 | |
| DAGHPREVELRFHLQ | 596 | Q9Y6N6 |